We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
0
0 active
Approvals
Total approvals
Agencies
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No approval data available
- Sycamore Partners has completed its acquisition of Walgreens Boots Alliance, taking the pharmacy giant private in partnership with Stefano Pessina and his family. - WBA shareholders received $11.45 per share in cash consideration, with potential for an additional $3.00 per share from future VillageMD monetization proceeds. - Following the transaction closure, Walgreens, Boots Group, Shields Health Solutions, CareCentrix and VillageMD will operate as separate standalone companies under private ownership. - The acquisition removes WBA from Nasdaq trading and marks a new chapter for the global pharmacy and healthcare services conglomerate.
